Raleigh, NC (PRWEB) May 18, 2012
Agile Sciences announced today that it has been awarded $257,000 from the National Institutes of Health (NIH) to advance the development of the company’s novel technology for enhancing the effectiveness of antiseptics.
Infection control in the hospital setting, especially during surgical procedures, is a major public health concern. Approximately 290,000 surgical site infections occur in the US each year, resulting in a total annual expense of $3-$9 billion. Most surgical site infections can be traced to bacterial flora from the patients’ skin that enter the surgical site.
Principle Investigator Dr. Angela Pollard stated, “Our initial results have demonstrated the ability of Agile Sciences’ technology to improve the efficacy of all major antimicrobials that are used as pre-surgical cleansers for patients. We are excited that this grant award will allow us to further evaluate this activity against common skin and drug-resistant bacteria.”
Dr. Eva Garland, Vice President of Research and Development, commented “We are grateful to the NIH for this grant award to further the development of our technology as an antimicrobial enhancer for infection treatment and control.”
About Agile Sciences:
Agile Sciences is headquartered on North Carolina State University's Centennial Campus. The company was founded in 2007 to addresses environmental and health issues caused by microbes, including biofilms and biocide resistance. The Company’s Agilyte® small molecules enhance the performance of microbicides and antibiotics toward fungal and bacterial pathogens. For additional information, please visit: http://www.agilesci.com.